SK Chemicals Co. Ltd., Teijin sales and marketing update

Teijin launched Feburic febuxostat in Japan and Korea to treat hyperuricemia. Partner SK Chemicals will market the non-purine selective inhibitor of xanthine oxidase in Korea under a 2004 deal. The Japanese National Health Insurance price is ¥31.10 ($0.40), ¥56.40 ($0.73) and ¥106.60 ($1.38) for a 10, 20 or 40 mg tablet, respectively. ...